Castle Biosciences Inc (CSTL)

EBITDA Growth

-109.94%

TTM · Period ending:

CSTL logo

CSTL EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-109.94%
CSTL TTM EBITDA YoY % (373.24% → -109.94%)
High-resolution chart · PNG

CSTL ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Castle Biosciences Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-109.9352%
-106.1717%
-70.258%
-4.2946%
248.0923%
328.2844%
184.7059%
139.5396%
112.1444%
71.3256%
22.8301%
-16.7381%
-61.4822%
-13.5011%
-59.3924%
-100.1068%
-136.0511%
-336.8295%
-415.9853%
-18,423.4802%
-284.7518%
-205.0962%
-169.0212%
-98.754%
429.5501%
1,302.008%
373.2399%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.